Impact has successfully managed clinical trials in a variety of therapeutic areas and phases. From Phase I to Phase III to post-submission trials, our experience is extensive. We also have experience with post-marketing trials to support labeling extensions
The executive team at IMPACT Clinical brings over 20 years of direct clinical trial management experience. Our CRAs are seasoned professionals in specific therapeutic areas.
IMPACT has extensive experience in the conduct and management of clinical trials in the following therapeutic areas:
- Asthma
- Allergic Rhinitis
- Anti-microbial therapies
- Cardiovascular
- COPD
- Cystic
- Fibrosis
- Diabetes
- Infectious Disease
- Immunology
- Oncology
- Brain
- Breast
- Colorectal
- Dermatology
- Head & Neck
- Leukemia
- Lymphomas
- Lung
- Melanoma
- Multiple Myeloma
- Ovarian
- Pancreas
- Prostate
- Immuno-therapy
- Checkpoint inhibitors
- PD-1/PD-L1 combination trials with novel checkpoint and kinase inhibitors in a range of indications
- Gene therapy and oncolytic virus approaches in solid tumors
- Next-generation antibodies: tetravalent, bispecific and antibody drug conjugates
NEED HELP?
Let's discuss your project needs.
Therapeutic area expertise is one important element of an effective team player but equally important is project management skills, pragmatic skills, team management skills,and leadership skills. These are the skills that every Impact consultant brings to your team.